Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment
- 2 July 2024
- journal article
- review article
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 17 (2)
Abstract
Glaucoma is one of the world’s primary causes of blindness. Russia is following the global increasing trends of glaucoma and its leading position among ophthalmic pathologies that cause irreversible loss of vision. Elevated intraocular pressure (IOP) is the only modifiable risk factor of glaucoma, so treatment strategies specifically focus on reducing IOP by suppressing the production of intraocular fluid and boosting its outflow. The current review presents new medications aimed at glaucoma and high IOP control that have recently appeared at the international market as well as the drugs under the different stages of development, from experimental to clinical studies. These include both the developments of agents belonging to the existing classes and of entirely new drugs intended to control IOP. In an attempt to reduce the side effects of locally administered drugs and prolong their action, in parallel with the development of new drugs, there is also evidence of alternative methods of drug delivery: intraocular implants, injectable forms and obturators, combinations of polymers and colloidal systems.Keywords
This publication has 29 references indexed in Scilit:
- Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle GlaucomaOphthalmology and Therapy, 2020
- 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma PatientsDrugs, 2019
- Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular HypertensionOphthalmology, 2018
- Unconventional aqueous humor outflow: A reviewExperimental Eye Research, 2017
- Effect of Pilocarpine Hydrochloride on the Schlemm Canal in Healthy Eyes and Eyes With Open-Angle GlaucomaJAMA Ophthalmology, 2016
- Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular InsertOphthalmology, 2016
- Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractilityExperimental Eye Research, 2014
- In Vitro and In Vivo Efficacy of SYL040012, a Novel siRNA Compound for Treatment of GlaucomaMolecular Therapy, 2014
- Intraocular Pressure–Lowering Effects of All Commonly Used Glaucoma DrugsOphthalmology, 2005
- The Ocular Hypertension Treatment StudyArchives of Ophthalmology (1950), 2002